Press Release HOME > NEWS > Press Release PharmCADD has been certified ‘Intellectual Property Management Enterprise’ from the Korean Intellectual Property Office. READ MORE PharmCADD showed proprietary AI technology at Medicine-Bio Forum 2022. READ MORE PharmCADD was selected into the KOREA AI STARTUP 100 list. READ MORE PharmCADD participated in AI KOREA 2022. READ MORE “AI” will accellerate the drug developement. READ MORE PharmCADD won “2022 AI KOREA Awards” from The Ministry of Trade, Industry and Energy. READ MORE PharmCADD & ISU ABXIS jointly develop a medicine for the treatment of neurofibromatosis type 1 (NFI) READ MORE “Break the New Drug development limits through AI based on Quantum Mechanics.” READ MORE Top 50 Pharma-Bio Companies, Started Quantum Jump by developing New AI Drugs. READ MORE « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
PharmCADD has been certified ‘Intellectual Property Management Enterprise’ from the Korean Intellectual Property Office. READ MORE
PharmCADD & ISU ABXIS jointly develop a medicine for the treatment of neurofibromatosis type 1 (NFI) READ MORE